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Tuberculosis (TB) is the 7th leading cause of death and disability worldwide and has reached epidemic proportions in both 
developed and undeveloped  nations. Approximately 5 to 10% of tuberculosis cases involve the brain and central nervous system. 
Tuberculomas account for 10 to 30% of intracranial (IC) masses in TB-endemic areas. The clinical and neuroimaging features of 
tuberculoma are variable and may pose a diagnostic challenge in the absence of systemic TB or tuberculous meningitis. Intracranial 
brain parenchymal tuberculomas may form paradoxically, days to months after starting antituberculous drug therapy. 
Tuberculomas may develop in and around optic chiasm and optic nerves after institution of antituberculous treatment as a quite rare 
occurrence in TBM this may lead to severe visual loss if not treated properly. We describe a 5 year-old child with documented 
TBM being treated with first line antituberculous drugs which developed visual impairment 3 months after starting the treatment. 
MRI after gadolinium administration revealed multiple perichiasmatic ring enhancing lesions due to tuberculomas. We 
recommended a treatment with corticosteroids and antituberculous therapy. Visual impairment developing in a patient on treatment 
with antituberculous drugs should give rise to a suspicion of rare optochiasmatic tuberculomas; this necessitates urgent contrast-
enhanced MRI of the brain and prompt treatment with steroids.   
 
 Introduction 
 Central nervous system (CNS) involvement is seen in about 10% of patients with tuberculosis, and this 
is more common in developing countries (1, 2). CNS tuberculosis may manifest in diffuse form with meningitis 
or in focal form as intracranial tuberculomas (1). Neuro-ophthalmologic complications of tuberculous meningitis 
include oculomotor nerve palsy, pupillary abnormalities and optic disc changes of papillitis, papilledema, or 
optic atrophy (3). These complications are seen in the late stage of tuberculous meningitis (TBM), usually 
manifesting in the elderly (4). Intracranial tuberculomas may enlarge or develop afresh as a paradoxical response 
to ongoing antituberculous chemotherapy for tuberculous meningitis TBM). Tuberculomas may rarely develop 
during treatment of TBM around the anterior optic pathway including the optic nerve and optic chiasm, 
threatening vision (5). We describe paradoxical development of tuberculomas in the anterior optic pathway 
demonstrated by MRI in a case of TBM who complained of progressive loss of vision during the 2
nd
 month of 
antituberculous therapy (ATT). 
 
 Case Report 
 A 5-year-old child, taking ATT since 3 months for tuberculous meningitis, presented with progressive 
diminution in both eyes and headache for the last 10 days. He started taking ATT as a combination of 
rifampicin, isoniazid, pyrazinamide and ethambutol, as well as corticosteroids for two weeks. After he had been 
diagnosed with imaging examination and also in laboratory, tuberculous meningitis has been confirmed in the 
infective clinic of the Kosovo University Clinical Center. At the time of hospitalization, the child did not have 
any problems with his sight; while in the neurological aspect, positive meningeal syndrome was present. The 
patient reported full compliance with the antituberculous drug regime and his clinical condition improved 
gradually. After the initial improvement with ATT, he started to suffer vision diminution. The examination 
presented vision diminution, and fundoscopy that showed bilateral papilledema. His serology was negative for 
human immunodeficiency virus (HIV). On 27 January 2014, a brain MRI was performed on a 1.5 tesla MRI 
system in the General Hospital ‗Rezonanca‘ in Prishtina. Using T1-weighted (T1W) and T2-weighted (T2W) 
sequences in axial, coronal and sagittal plans; this was followed by intravenous administration of gadolinium 
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containing contrast agent and subsequent T1W imaging in all the plans. MRI showed multiple rounded lesions 
with hyperintense signal intensity wall on T1W sequence in the suprasellar cistern.  
 
 
 
Fig. 1 
T2W images showed round lesions filling suprasellar cistern (Figure 1). 
 
      
                                                   Fig. 2      Fig. 3 
 
      Fig. 4 
 
 Post-gadolinium enhanced T1W images depicted multiple ring enhancing lesions clustered around 
opticchiasma in the suprasellar cistern (Figures 2, 3 & 4). Clinical features and imaging findings were 
compatible with a diagnosis of TBM with optochiasmatic tuberculomas resulting in neuro-opthalmologic 
manifestations, possibly due to paradoxical response to treatment. We have recommended a continuation of 
treatment with ATT along with corticosteroids. We are still waiting for a successful finalization of this therapy.  
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 Discussion 
 Visual loss in TBM resulting from involvement and inflammation of the optic chiasm and optic nerves 
is a rare occurrence (6, 7). Visual loss developing during treatment of TBM may be related to drug toxicity and 
arachnoiditis besides tuberculomas involving the anterior optic pathway. The optochiasmatic region may be a 
rare location involved by paradoxical development of intracranial tuberculomas during ATT for CNS or 
pulmonary tuberculosis (6, 7, 8).  
 Pathogenesis of this paradoxical development and/or expansion of tuberculomas have been attributed to 
exaggerated host reaction to tuberculous protein in a patient being successfully treated with ATT (1, 5). Role of 
corticosteroids in controlling tuberculomas in this situation is more likely due to an effect on this host response 
rather than reduction of associated edema. The paradoxical response resulting in optochiasmatic tuberculomas 
has important diagnostic and therapeutic implications (1, 6, 7). 
 Early recognition of this condition and continued ATT and corticosteroid therapy or surgical 
decompression of optic pathway may help in preserving the visual function of the patient (1, 7, 8). The treating 
neurologist and ophthalmologist need to be aware of such a rare occurrence of paradoxical optochiasmatic 
tuberculomas as a cause of visual impairment in the spectrum of tuberculosis and its treatment. This awareness 
and proper clinical judgment helps in timely recognition of this phenomenon in a patient on ATT who needs to 
be closely followed (8). Satisfactory initial response to ATT, no associated systemic features and persistent 
sensitivity of isolated Mycobacterium tuberculosis to the instituted first line antituberculous drugs favoured a 
diagnosis of paradoxical response against progressive drug resistant infection in our case. MRI helps in early 
detection of intracranial tuberculomas which are seen as ring enhancing lesions after contrast administration. 
Intracranial tuberculomas are usually parenchymal and extra-axial location in CSF spaces is exceedingly rare. 
Optochiasmatic tuberculomas may be intrachiasmatic or perichiasmatic in location; this differentiation is 
difficult even with MRI (1).  
 Multiple ring enhancing lesions due to tuberculomas on MRI need to be differentiated from 
neurocysticercosis, pyogenic abscesses, metastasis and toxoplasmosis. Clinical features, serology and CSF 
findings are helpful besides imaging to arrive at proper diagnosis. Optochiasmatic tuberculomas also need to be 
considered in the differential diagnosis of optic nerve and perichiasmatic tumors in view of prevalent TB (9).  
 Using MRI, the exact location and relationship of tuberculomas with respect to the optic nerve and 
chiasm can be determined. This helps in planning surgical decompression of optochiasmatic tuberculomas 
threatening vision. For the treatment of paradoxical development of tuberculomas, antituberculous drugs are 
continued as usual and systemic corticosteroids are added (1, 5). Steroids overcome the inflammatory response 
of the host body to the breakdown products of killed Mycobacterium tuberculosis (10). ATT is continued up to 
24-30 months, though a shorter course has been reported to be effective as well (1). Corticosteroid therapy is 
continued for 6-8 weeks and withdrawn after gradual tapering. Failure of medical therapy is an indication for 
urgent surgical decompression (8). Timely decompression of optochiasmatic region is important for a favorable 
visual recovery. Prompt surgical intervention for tuberculomas of the anterior optic pathway is facilitated by 
MRI by providing a roadmap. 
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 Conclusion 
 Paradoxical development of optochiasmatic tuberculomas may present as visual impairment in a patient 
on ATT for TBM. MRI demonstrates ring enhancing lesions around the optic chiasm and aids in the 
management by helping in timely diagnosis and follow-up. Corticosteroid therapy may achieve satisfactory 
decompression and preserve vision. 
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